Globus Medical Inc GMED
5 trading plans running, 13 Form 144 notices for $18.8M
10-Q, 10-K and Form 144What GMED's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Dec 4, 2024 to Nov 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Kyle R. Kline Chief Financial Officer and Senior Vice President |
Adopted 10b5-1 plan | Aug 31, 2026 | 10-Q Nov 5, 2026 | ||
What the company wroteOn August 31, 2026, Kyle R. Kline, Chief Financial Officer and Senior Vice President, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Kline’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) November 30, 2027 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 25,493 shares of Class A Common pursuant to the terms of the plan. | |||||
| Ann D. Rhoads a member of the Board |
Adopted 10b5-1 plan | Jun 10, 2026 | 10-Q Aug 6, 2026 | ||
What the company wroteOn June 10, 2026, Ann D. Rhoads, a member of the Board, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Ms. Rhoads’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) September 10, 2027 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 25,000 shares of Class A Common pursuant to the terms of the plan. | |||||
| Keith W. Pfeil Chief Executive Officer and President |
Ended 10b5-1 plan | Feb 27, 2026 | 10-Q May 7, 2026 | ||
What the company wroteOn March 13, 2026, Keith W. Pfeil, the Company’s Chief Executive Officer and President, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Pfeil’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) June 12, 2027 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 90,000 shares of Class A Common pursuant to the terms of the plan. | |||||
| Berachah Foundation member of the Board |
Adopted 10b5-1 plan | Dec 10, 2025 | 10-K Feb 24, 2026 | ||
What the company wroteOn December 10, 2025, Berachah Foundation (David D. Davidar's Foundation), a foundation of a member of the Board, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. The foundation’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) December 31, 2026 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 9,100 shares of Class A Common pursuant to the terms of the plan. | |||||
| David D. Davidar member of the Board |
Adopted 10b5-1 plan | Dec 10, 2025 | 10-K Feb 24, 2026 | ||
What the company wroteOn December 10, 2025, David D. Davidar, a member of the Board, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Davidar’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) December 31, 2026 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 36,000 shares of Class A Common pursuant to the terms of the plan. | |||||
| Kelly G. Huller Executive Vice President and General Counsel |
Adopted 10b5-1 plan | Nov 12, 2025 | 10-K Feb 24, 2026 | ||
What the company wroteOn November 12, 2025, Kelly G. Huller, the Company's Executive Vice President and General Counsel, adopted a trading plan intended to satisfy the condition under Rule 10b5-1(c) of the Exchange Act. Ms. Huller’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) February 7, 2027 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 67,500 shares of Class A Common pursuant to the terms of the plan. | |||||
| Leslie V. Norwalk Member of the Board of Directors |
Adopted 10b5-1 plan | Sep 12, 2025 | 10-Q Nov 6, 2025 | ||
| Kyle R. Kline Chief Financial Officer and Senior Vice President |
Adopted 10b5-1 plan | Aug 25, 2025 | 10-Q Nov 6, 2025 | ||
| Daniel T. Scavilla President and Chief Executive Officer |
Ended 10b5-1 plan | Aug 12, 2025 | 10-Q Nov 6, 2025 | ||
| Keith Pfeil Executive Vice President, Chief Operating Officer and Chief Financial Officer |
Adopted 10b5-1 plan | Mar 15, 2025 | 10-Q May 8, 2025 | ||
| Daniel T. Scavilla President and Chief Executive Officer |
Adopted 10b5-1 plan | Dec 10, 2024 | 10-K Feb 20, 2025 | ||
| Kelly Huller Executive Vice President and General Counsel |
Adopted 10b5-1 plan | Dec 4, 2024 | 10-K Feb 20, 2025 | ||
| Ann D. Rhoads Director |
Adopted 10b5-1 plan | Nov 11, 2024 | 10-K Feb 20, 2025 | ||
| Kelly G. Huller Senior Vice President and General Counsel |
Adopted 10b5-1 plan | Jun 13, 2024 | 10-Q Aug 6, 2024 | ||
| Daniel T. Scavilla President and Chief Executive Officer |
Adopted 10b5-1 plan | Jun 7, 2024 | 10-Q Aug 6, 2024 | ||
| Keith W. Pfeil Chief Operating Officer and Chief Financial Officer |
Adopted 10b5-1 plan | Dec 15, 2023 | 10-K Feb 21, 2024 | ||
| David D. Davidar Irrevocable Trust |
Adopted 10b5-1 plan | Dec 14, 2023 | 10-K Feb 21, 2024 | ||
| David D. Davidar Director |
Adopted 10b5-1 plan | Dec 14, 2023 | 10-K Feb 21, 2024 | ||
| Leslie V. Norwalk Director |
Adopted 10b5-1 plan | Dec 14, 2023 | 10-K Feb 21, 2024 | ||
Show the other 11 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 10, 2026 | TOBIN JAMES R Director |
41,666 | $3.1M |
| Nov 4, 2026 | RHOADS ANN D Director |
5,000 | $425K |
| Sep 15, 2026 | TOBIN JAMES R Director |
30,000 | $2.2M |
| Aug 18, 2026 | ZARRILLI STEPHEN T Director |
25,000 | $2.2M |
| Jun 5, 2026 | Davidar David D Director |
25,000 | $2.0M |
| Apr 14, 2026 | DeFord John A Former Director |
30,000 | $2.8M |
| Feb 25, 2026 | Huller Kelly Officer |
20,000 | $1.9M |
| Feb 12, 2026 | Huller Kelly Officer |
10,000 | $876K |
| Jan 8, 2026 | Kline Kyle Officer |
3,594 | $363K |
| Jan 8, 2026 | Norwalk Leslie V Director |
2,000 | $202K |
| Dec 12, 2025 | Norwalk Leslie V Director |
4,000 | $355K |
| Dec 1, 2025 | Kline Kyle Officer |
18,542 | $1.7M |
| Nov 25, 2025 | Huller Kelly Officer |
7,500 | $675K |
Show the other 5 notices
From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/GMED/export.csv") into a cell.